News
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
13d
News Medical on MSNNK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trialA novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
23d
Clinical Trials Arena on MSNRactigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancerThe company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01.
Electric vehicles (EVs) conjure images of quick charging, low maintenance, and fresh air. However, most people are unaware ...
We Care About Your Privacy By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance ...
Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials ...
If you're constantly battling colds, your spleen could be the hidden reason. Discover how this organ affects your immune defenses.
We took advantage of the multimeric structure and extraordinary antigen sensitivity of natural T cell receptors (TCRs ... While the emergence of immune checkpoint inhibitors has improved cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results